Back to News
Market Impact: 0.1
BODYWELLE Announces Exclusive Use of ZEO ScientifiX Biologics for Pain, Joints, and Wound Care Treatments
Source: Newswire
Healthcare & Biotech
A Miami Beach practice now uses quantified stem cell and extracellular vesicle products, plus an autologous option derived from patients’ own platelets. The report provides no efficacy, commercial, or financial details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- AstraZeneca CEO says Summit drug could drive next generation of cancer combinations after $2 billion investment
- Up 57% since June: this AI-picked pharma stock keeps climbing
- Why is NeoGenomics stock sliding today?
- BTIG reiterates Vaxcyte stock rating on strong VAX-31 trial data
- These stocks could benefit from a midterm election shake-up, JPMorgan says
- NeoGenomics stock falls on CEO transition announcement